BTW
GMED icon

Boston Trust Walden’s Globus Medical GMED Stock Holding History

Boston Trust Walden’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108M Sell
1,254,910
-113,077
-8% -$10.1M 0.89% 17
2025
Q4 		$119M Buy
1,367,987
+182,526
+15% +$13.9M 0.9% 17
2025
Q3 		$67.9M Buy
+1,185,461
New +$68.3M 0.5% 73
2025
Q1 		– Sell
-619,652
Closed -$51.3M – 382
2024
Q4 		$51.3M Sell
619,652
-110,272
-15% -$8.7M 0.36% 110
2024
Q3 		$52.2M Sell
729,924
-18,205
-2% -$1.29M 0.36% 112
2024
Q2 		$51.2M Sell
748,129
-609
-0.1% -$36.4K 0.38% 107
2024
Q1 		$40.2M Sell
748,738
-1,283
-0.2% -$69K 0.29% 130
2023
Q4 		$40M Buy
750,021
+2,173
+0.3% +$106K 0.3% 129
2023
Q3 		$37.1M Buy
747,848
+46,580
+7% +$2.6M 0.31% 115
2023
Q2 		$41.8M Buy
701,268
+20,751
+3% +$1.18M 0.34% 108
2023
Q1 		$38.5M Buy
680,517
+18,502
+3% +$1.19M 0.33% 113
2022
Q4 		$49.2M Sell
662,015
-3,118
-0.5% -$212K 0.43% 79
2022
Q3 		$39.6M Buy
665,133
+22,893
+4% +$1.38M 0.39% 91
2022
Q2 		$36.1M Buy
642,240
+6,024
+0.9% +$396K 0.34% 108
2022
Q1 		$46.9M Buy
636,216
+149,126
+31% +$10.4M 0.39% 94
2021
Q4 		$35.2M Sell
487,090
-2,945
-0.6% -$214K 0.28% 125
2021
Q3 		$37.5M Buy
490,035
+9,821
+2% +$789K 0.33% 107
2021
Q2 		$37.2M Sell
480,214
-20,009
-4% -$1.42M 0.33% 110
2021
Q1 		$30.8M Sell
500,223
-5,937
-1% -$376K 0.3% 121
2020
Q4 		$33M Buy
506,160
+999
+0.2% +$57.4K 0.35% 96
2020
Q3 		$25M Buy
505,161
+22,152
+5% +$1.14M 0.31% 108
2020
Q2 		$23M Buy
483,009
+40,220
+9% +$1.94M 0.31% 103
2020
Q1 		$18.8M Buy
442,789
+11,580
+3% +$572K 0.3% 106
2019
Q4 		$25.4M Buy
431,209
+7,917
+2% +$430K 0.3% 103
2019
Q3 		$21.6M Buy
423,292
+118,336
+39% +$5.64M 0.27% 111
2019
Q2 		$12.9M Buy
304,956
+2,548
+0.8% +$111K 0.17% 173
2019
Q1 		$14.9M Buy
302,408
+1,549
+0.5% +$70.1K 0.2% 144
2018
Q4 		$13M Sell
300,859
-11,290
-4% -$563K 0.21% 144
2018
Q3 		$17.7M Sell
312,149
-19,713
-6% -$1.04M 0.24% 121
2018
Q2 		$16.7M Sell
331,862
-8,580
-3% -$447K 0.25% 125
2018
Q1 		$17M Sell
340,442
-25,171
-7% -$1.18M 0.26% 121
2017
Q4 		$15M Sell
365,613
-9,728
-3% -$341K 0.22% 133
2017
Q3 		$11.2M Sell
375,341
-3,542
-0.9% -$108K 0.17% 170
2017
Q2 		$12.6M Sell
378,883
-115,712
-23% -$3.63M 0.2% 145
2017
Q1 		$14.7M Sell
494,595
-27,867
-5% -$761K 0.23% 145
2016
Q4 		$13M Sell
522,462
-16,952
-3% -$385K 0.2% 163
2016
Q3 		$12.2M Buy
539,414
+775
+0.1% +$18.2K 0.2% 165
2016
Q2 		$12.8M Buy
+538,639
New +$12.9M 0.22% 160

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Trust Walden's GMED Position: Q1 2026 in Review

Boston Trust Walden reduced its Globus Medical (GMED) stake by 8.3% in Q1 2026, selling an estimated $10.1M and leaving 1,254,910 shares worth $108M. The position accounts for 0.89% of the portfolio, ranked #17.

Boston Trust Walden first reported a position in GMED in Q2 2016 and has held it in 38 quarters since. The position peaked at $119M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Boston Trust Walden held 1,254,910 shares of Globus Medical worth $108M as of Q1 2026.
  • Boston Trust Walden sold 113,077 Globus Medical shares in Q1 2026, an estimated $10.1M.
  • Globus Medical made up 0.89% of Boston Trust Walden's portfolio in Q1 2026, its #17 holding.
  • Boston Trust Walden first reported a position in Globus Medical in Q2 2016 and has held it in 38 quarters since.
  • Boston Trust Walden's Globus Medical position peaked at $119M in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Boston Trust Walden's 13F filing for Q1 2026, filed 24 Apr 2026.